 |
市場調查報告書
商品編碼
1672779
按產品類型、形式、應用、最終用戶和地區研究抗體市場Research Antibodies Market, By Product Type, By Form, By Application, By End User, By Geography |
||||||
價格
簡介目錄
2025 年全球研究抗體市場規模估計為 127.2 億美元，預計 2032 年將達到 201.7 億美元，2025 年至 2032 年的複合年成長率為 6.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 127.2億美元 |
| 效能資料 | 從 2020 年到 2024 年 | 預測期 | 2025 至 2032 年 |
| 預測期：2025-2032年複合年成長率： | 6.80% | 2032 年價值預測 | 201.7億美元 |
數字。 2025 年各地區抗體研究市場佔有率（%）
由於製藥和生物技術公司、學術機構和受託研究機構等各個終端使用領域對抗體的應用越來越多，全球研究抗體市場在過去幾年中見證了顯著成長。研究抗體被廣泛用作藥物開發過程和疾病診斷程序中的重要工具。它們在基礎科學和臨床研究中也發揮著重要作用。對蛋白質體學和癌症研究的投入不斷增加，推動了對研究抗體的需求。抗體工程和生產技術的進步正在進一步擴大其應用範圍。由於個人化醫療需求的不斷增加，全球研究抗體市場預計將成長。
市場動態：
全球研究抗體市場的成長主要受到世界各地慢性病和感染疾病增加的推動。複雜疾病的快速診斷和新型生技藥品的開發正在推動製藥業對研究抗體的需求。私人和公共機構對蛋白質組學和基於細胞的研究活動的投資不斷增加，可能為市場參與者提供有利可圖的機會。然而，抗體生產的高成本和抗體批准的嚴格監管標準可能會阻礙市場成長。預計全人單株抗體的開發和先進抗體生產技術的採用將在不久的將來為市場相關人員提供成長機會。
本研究的主要特點
- 本研究報告對全球研究抗體市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），以 2024 年為基準年。
- 它揭示了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 全球研究抗體市場的主要企業已根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行了分析。
- 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球研究抗體市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 可以透過用於分析全球研究抗體市場的各種策略矩陣來促進相關人員的決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 主要進展
- 監管情景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
4. 全球研究抗體市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 全球研究抗體市場，依產品類型，2020-2032 年（十億美元）
- 一抗
- 二抗
- 試劑
- 耗材
6. 全球研究抗體市場，依形式，2020-2032 年（十億美元）
- 單株抗體
- 多株抗體
- 重組抗體
7. 全球研究抗體市場，按應用分類，2020-2032 年（十億美元）
- 蛋白質印跡法
- ELISA
- 流式細胞技術
- 免疫細胞化學 (ICC)/螢光(IF)
- 免疫組織化學 (IHC)
- 其他（免疫沉澱分析法、多重免疫吸附等）
8. 2020-2032 年全球研究抗體市場（按最終用戶分類）（十億美元）
- 學術研究所
- 受託研究機構
- 製藥和生物技術公司
9. 2020 年至 2032 年全球研究抗體市場（按地區分類）（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章 競爭格局
- 公司簡介
- Thermo Fisher Scientific, Inc.
- Merck KGaA（including Sigma-Aldrich）
- Abcam plc
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Lonza Group AG
- GenScript Biotech Corporation
- BioLegend, Inc.
- Bio-Techne Corporation
- F. Hoffmann-La Roche Ltd
- Santa Cruz Biotechnology, Inc.
- BD Biosciences（Becton, Dickinson and Company）
- PerkinElmer, Inc.
- Active Motif
- QIAGEN NV
- OriGene Technologies, Inc.
- Jackson ImmunoResearch Laboratories, Inc.
- R&D Systems（part of Bio-Teachne Corporation）
- Proteintech Group, Inc.
- 機會
- 分析師觀點
- Coherent Opportunity Map
第 11 章 參考文獻與調查方法
- 參考
- 調查方法
簡介目錄
Product Code: CMI5247
Global Research Antibodies Market is estimated to be valued at USD 12.72 Bn in 2025 and is expected to reach USD 20.17 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 12.72 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.80% | 2032 Value Projection: | USD 20.17 Bn |
Figure. Research Antibodies Market Share (%), By Region 2025
Global research antibodies market has been witnessing significant growth over the past few years, owing to increasing adoption of antibodies across various end-use sectors including pharmaceutical and biotechnology companies, academic institutes, contract research organizations, and others. Research antibodies are widely used as indispensable tools in drug development processes and disease diagnosis procedures. These also play a vital role in basic science research and clinical discovery. Increasing investments in proteomics and cancer research have boosted demand for research antibodies. Technological advancements in antibody engineering and production further expand the scope of their applications. Global research antibodies market is expected to witness growth due to growing demand for personalized medicine.
Market Dynamics:
Global research antibodies market growth is primarily driven by increasing prevalence of chronic and infectious diseases worldwide. Rapid diagnosis of complex disorders and development of novel biologics boosts e demand for research antibodies in the pharmaceutical sector. Rising investments by private and public organizations in proteomics and cell-based research activities can offer lucrative opportunities for market players. However, high costs associated with antibody production and stringent regulatory norms for their approval can hamper the market growth. The development of fully human monoclonal antibodies and adoption of advanced antibody production technologies are expected to offer growth opportunities for the market players in the near future.
Key Features of the Study:
- This report provides in-depth analysis of the global research antibodies market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global research antibodies market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Thermo Fisher Scientific, Abcam PLC, Merck Group, Bio-Rad Laboratories, Cell Signaling Technology, F. Hoffmann-La Roche Ltd, Agilent Technologies, and Danaher Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global research antibodies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global research antibodies market.
Detailed Segmentation:
- By Product Type:
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Consumables
- By Form
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- By Application
- Western Blotting
- ELISA
- Flow Cytometry
- Immunocytochemistry (ICC)/ Immunofluorescence (IF)
- Immunohistochemistry (IHC)
- Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
- By End User
- Academic & Research Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Thermo Fisher Scientific, Inc.
- Merck KGaA (including Sigma-Aldrich)
- Abcam plc
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Lonza Group AG
- GenScript Biotech Corporation
- BioLegend, Inc.
- Bio-Techne Corporation
- Hoffmann-La Roche Ltd
- Santa Cruz Biotechnology, Inc.
- BD Biosciences (Becton, Dickinson and Company)
- PerkinElmer, Inc.
- Active Motif
- QIAGEN N.V.
- OriGene Technologies, Inc.
- Jackson ImmunoResearch Laboratories, Inc.
- R&D Systems (part of Bio-Teachne Corporation)
- Proteintech Group, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Form
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Research Antibodies Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Research Antibodies Market, By Product Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Primary Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Secondary Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reagents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Research Antibodies Market, By Form, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Polyclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Recombinant Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Research Antibodies Market, By Application, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Western Blotting
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- ELISA
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Flow Cytometry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunocytochemistry (ICC)/ Immunofluorescence (IF)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunohistochemistry (IHC)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Immunoprecipitation, Multiplex Immunosorbent Assay and etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Research Antibodies Market, By End User, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical & Biotechnology Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Research Antibodies Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck KGaA (including Sigma-Aldrich)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abcam plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cell Signaling Technology, Inc.
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Lonza Group AG
- GenScript Biotech Corporation
- BioLegend, Inc.
- Bio-Techne Corporation
- F. Hoffmann-La Roche Ltd
- Santa Cruz Biotechnology, Inc.
- BD Biosciences (Becton, Dickinson and Company)
- PerkinElmer, Inc.
- Active Motif
- QIAGEN N.V.
- OriGene Technologies, Inc.
- Jackson ImmunoResearch Laboratories, Inc.
- R&D Systems (part of Bio-Teachne Corporation)
- Proteintech Group, Inc.
- Thermo Fisher Scientific, Inc.
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
